Overview

Nicotine Lozenge Bioequivalence Study

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

To compare the bio equivalence of new nicotine lozenge formulation with the reference nicotine lozenge so as to deliver the same nicotine blood profile.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Nicotine